INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9865	Companies
198267	Keywords
129311	Articles
105440	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 11/13/2025 at 08:40, 3 months 1 day ago

Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris
Inventiva temporarily halts trading of ordinary shares on Euronext Paris for public offering preparation, with expected resumption by end of day. Company focuses on MASH treatment research

Euronext Paris Trading Halt Public Offering Inventiva MASH Treatment
BRIEF

published on 10/14/2025 at 22:05, 4 months ago

Inventiva lance un nouveau programme de distributeurs automatiques de billets pour lever 100 millions de dollars

Biopharmaceutique Dépôt Auprès De La SEC Inventiva Lanifibranor Programme ATM
BRIEF

published on 10/14/2025 at 22:05, 4 months ago

Inventiva Launches New ATM Program to Raise $100 Million

Biopharmaceutical SEC Filing Inventiva Lanifibranor ATM Program
PRESS RELEASE

published on 10/14/2025 at 22:00, 4 months ago

Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
Inventiva lance un nouveau programme de financement At-the-Market (ATM) pour une levée de fonds jusqu'c 100 millions de dollars, dans le but de soutenir le développement de thérapies contre la stéatohépatite

Financement Inventiva Stéatohépatite Thérapies ATM
PRESS RELEASE

published on 10/14/2025 at 22:00, 4 months ago

Inventiva Announces the Implementation of a New ATM Program
Inventiva implements new ATM program, files Registration Statement with the SEC for up to $100 million aggregate gross sales proceeds. Proceeds to fund research and development, working capital, and corporate purposes

Biopharmaceutical SEC Registration Statement Inventiva ATM Program
BRIEF

published on 10/07/2025 at 22:05, 4 months 7 days ago

Inventiva at Liver Meeting 2025: Key Presentations on Lanifibranor

Digital Pathology Inventiva MASH Lanifibranor Liver Meeting 2025
BRIEF

published on 10/07/2025 at 22:05, 4 months 7 days ago

Inventiva au Liver Meeting 2025 : Présentations Clés sur Lanifibranor

Pathologie Numérique Inventiva MASH Lanifibranor Liver Meeting 2025
PRESS RELEASE

published on 10/07/2025 at 22:00, 4 months 7 days ago

Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
Inventiva présentera plusieurs abstracts au congrès AASLD The Liver Meeting® 2025. Présentation d'une comparaison histologie numérique sur lame biopsies NATiV3 et pathologie numérique de lanifibranor préclinique

Pathologie Numérique Inventiva Lanifibranor AASLD The Liver Meeting 2025 Histologie Numérique
PRESS RELEASE

published on 10/07/2025 at 22:00, 4 months 7 days ago

Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
Inventiva to present multiple abstracts at AASLD The Liver Meeting® 2025 showcasing digital pathology data and therapeutic benefits of lanifibranor in MASH treatment. Visit booth #745 for more

Digital Pathology Inventiva MASH Lanifibranor AASLD The Liver Meeting
BRIEF

published on 10/01/2025 at 08:35, 4 months 13 days ago

Andrew Obenshain Appointed as CEO of Inventiva

Leadership Transition Drug Development Inventiva MASH Treatment Andrew Obenshain

Accesswire

Published on 02/14/2026 at 01:00, 1 day ago

Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:30, 1 day 2 hours ago

Norse Gold Corp. Announces New Director
Published on 02/13/2026 at 22:15, 1 day 3 hours ago

Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 7 hours ago

Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 10 hours ago

Datametrex Received $500,000 Purchase Order For Data Centre Solutions

View all ACCESSWIRE

EQS Group

Published on 02/14/2026 at 16:30, 8 hours 57 minutes ago

Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 19 hours 22 minutes ago

The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 6 hours ago

Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 6 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 7 hours ago

GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE

Les Echos

Published on 02/14/2026 at 07:00, 18 hours 27 minutes ago

Groupe DLSI - Chiffre d'affaires 2025
Published on 02/13/2026 at 18:05, 1 day 7 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 7 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 7 hours ago

Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 7 hours ago

Nombre total d'actions et droits de vote - janvier 2026

View all LES ECHOS COMFI WIRE